1. Home
  2. REPL vs HLF Comparison

REPL vs HLF Comparison

Compare REPL & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$22.28

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Herbalife Ltd.

HLF

Herbalife Ltd.

N/A

Current Price

$15.73

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REPL
HLF
Founded
2015
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
REPL
HLF
Price
$22.28
$15.73
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
★ $23.33
$17.33
AVG Volume (30 Days)
★ 3.0M
1.7M
Earning Date
10-28-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.88
Revenue
N/A
★ $5,037,500,000.00
Revenue This Year
N/A
$4.97
Revenue Next Year
$513.15
$2.50
P/E Ratio
★ N/A
$17.38
Revenue Growth
N/A
★ 0.89
52 Week Low
$1.50
$8.65
52 Week High
$21.91
$20.40

Technical Indicators

Market Signals
Indicator
REPL
HLF
Relative Strength Index (RSI) 81.09 70.15
Support Level $7.11 $15.61
Resistance Level N/A $17.46
Average True Range (ATR) 1.43 0.67
MACD 0.90 0.18
Stochastic Oscillator 96.10 96.95

Price Performance

Historical Comparison
REPL
HLF

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

About HLF Herbalife Ltd.

Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.

Share on Social Networks: